| NDC Code | 64764-300-20 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 64764-300 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Entyvio |
|---|
| Non-Proprietary Name | Vedolizumab |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20140520 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125476 |
|---|
| Manufacturer | Takeda Pharmaceuticals America, Inc. |
|---|
| Substance Name | VEDOLIZUMAB |
|---|
| Strength | 300 |
|---|
| Strength Unit | mg/5mL |
|---|
| Pharmacy Classes | Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA] |
|---|